Recent work using targeted sequencing of UC samples with a high risk of developing colorectal carcinoma indicates that BRG1 is frequently mutated37, suggesting that BRG1 plays a potential role in inflammatory settings, such as colitis and colitis-CRC transformation. This evidence concerns the gene SMARCA4 and colorectal carcinoma.